HPV data can be used as a cytopathology laboratory quality indicator

Diagnostic Cytopathology

Volumn 38, Issue 2, 2010, Pages 159-160

  Pantanowitz, Liron ^a   Hornish, Maryanne ^a   Cao, Q Jackie ^a   Goulart, Robert A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLPOSCOPY; CYTOPATHOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; LABORATORY DIAGNOSIS; LABORATORY TEST; LETTER; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; QUALITY CONTROL; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

CYTODIAGNOSIS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LABORATORIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, CLINICAL; PRECANCEROUS CONDITIONS; QUALITY ASSURANCE, HEALTH CARE; VAGINAL SMEARS;

EID: 74849136468     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21186     Document Type: Letter

References (7)

1. Chhieng DC, Bakdounes K, Connolly M, Gallaspy S, Roberson J, Eltoum I. HPV detection rate in discordant Pap tests between cytotechnologists and pathologists. Diagn Cytopathol 2009;37:320-323.
2. Sherman ME, Schiffman MH, Lorincz AT, et al. Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol 1994;102:182-187.
3. Zuna RE, Dunn ST. Can HPV testing function as an objective quality assurance monitor in the cytopathology laboratory? LabMedicine 2004;35:238-240.
4. Davey DD. Reflex human papillomavirus testing; leave the cytology interpretation alone. Cancer Cytopath 2003;99:187-190.
5. Tworek JA, Jones BA, Raab S, Clary KM, Walsh MK. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: A College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med 2007;131:1525-1531.
6. Zuna RE, Moore W, Dunn ST. HPV DNA testing of the residual sample of liquid-based Pap test: Utility as a quality assurance monitor. Mod Pathol 2001;14:147-151.
7. Moriarty AT, Schwartz MR, Eversole G, et al. Human papillomavirus testing and reporting rates: Practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006. Arch Pathol Lab Med 2008;132:1290-1294.